IgA1 (immunoglobulin A1) antibodies are the first line of defence against microbial pathogens such as Neisseria meningitidis and Haemophilus influenzae. However, these bacteria secrete a site-specific protease that is capable of cleaving human IgA1 and interacting with other host components. The IgA proteases are released by the type V secretion pathway, which involves translocation through two membranes and an autolytic, post-translational processing step. Results reported recently throw light on the type V secretion pathway and on the roles of the multifunctional IgA protease. The IgA1 protease-recognition sequence is present within the IgA1 hinge region as well as in the variable sequence connecting the IgA1 protease to its translocator domain. Recent results suggest that neisserial IgA1 proteases are capable of cleaving substrates lacking the classical recognition sequence. This review will cover recent advances in the IgA protease field.
Immunoglobulin A1 proteases: a structure-function update Introduction
Neisseria meningitidis and Haemophilus influenzae are responsible for a significant proportion of life-threatening bacterial infections such as septicaemia and meningitis. These organisms frequently colonize the nasopharyngeal tract and, in most cases, a period of asymptomatic carriage occurs, during which the mucosal immune system will usually deal with the invader. However, if this fails, the organism can enter normally sterile sites and cause significant pathology. The predominant antibody present on the mucosal surfaces of the nasopharynx is IgA1 (immunoglobulin A1). These antibodies are important in combating microbial pathogens. They bind and agglutinate the potential pathogen, allowing the expulsion of the organisms via the mucociliary escalator [1] . However, bacterial pathogens, including N. meningitidis and H. influenzae, are capable of producing extracellular IgA1 proteases that can cleave the hinge region of human IgA1 [2] (Figure 1) , thus separating the antigen-binding fragment (Fab) and constant regions (Fc). The consequences of this cleavage are 2-fold. Agglutination and mechanical clearance are impeded, and the Fab released is still capable of binding the cognate antigen, thus masking bacterial surface epitopes from subsequent recognition by intact immunoglobulins.
Type V secretion
The neisserial IgA1 proteases are characterized by a polyprotein precursor molecule having four separate domains. These include an N-terminal signal peptide sequence, capable of targeting translocation to the periplasm via the Sec pathway; a surface-directed mature protease domain, a variable region Key words: host-pathogen interaction, immunoglobulin A1 (IgA1), membrane protein, protease, translocation, type V secretion.
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with high α-helical content known as the α-protein and a membrane-embedded C-terminal region that forms a β-barrel in the outer membrane, through which the mature protein is exported, the so-called β-core. The neisserial IgA1 protease was the first example of the type V, or autotransporter, secretion mechanism [3] . This pathway is extraordinarily simple when compared with the other export systems (Figure 2) . The model initially proposed for autosecretion involved the N-terminus of the protease domain threading through the centre of the β-barrel structure supposed to be formed by the β-core [3] . However, this model requires that the protease domain of some 1000 or so amino acids must thread through the centre of the β-core whose inner surface is probably hydrophilic. An alternative model has been presented by Veiga et al. [4] , who observed large pores consisting of assemblies of several β-core molecules in the outer membrane. The oligomeric ring structure creates pores with a diameter of 2 nm. Thus translocation of the N-terminal protease domain could occur via this large pore, a more probable scenario compared with threading through the centre of a β-barrel. However, a recent crystal structure of a related neisserial autotransporter, NalP, provides support for the original threading model [5] . It shows an α-helical segment threading through the 12-stranded β-barrel structure formed by the β-core ( Figure 2 ). These results might suggest that the threading model is not so unlikely after all, but the structure could also be the result of an artifact due to the refolding method used to generate the NalP autotransporter used in structure determination.
Virulence factor or irrelevant factor?
The significance of IgA1 proteases as virulence factors has been hard to pin down, largely due to the lack of good animal models of infection. Since the hinge region of human IgA1 is unique to humans, any model system that lacks susceptible IgA1 will be less than satisfactory. Results of organ culture models of infection showed that wild-type and isogenic iga mutants of N. meningitidis and H. influenzae behaved similarly in such models. However, the levels of IgA1 protease production in the wild-type organisms and the concentrations of cognate and non-cognate antibodies were not clearly defined in these experiments [6, 7] . Countering these findings, perhaps the most persuasive direct evidence for a role in pathogenesis has been presented by So and coworkers [8] . They have shown that IgA1 protease-deficient gonococci translocate through a polarized monolayer of epithelial cells significantly less efficiently compared with their parental IgA1 protease-positive parental strain. Clearly, this is an important step in the progression from carriage state to invasion and full-blown systemic disease.
The ability to cleave human IgA1 would seem to be an obvious advantage to a potential pathogen as it would aid in evading the host immune system; however, the presence of anti-meningococcal antibodies is protective, indicating that the role of IgA1 protease, despite its name, may not be due to its capacity to cleave cognate antibodies. Quantitative studies on carriage and invasive isolates of N. meningitidis and H. influenzae have demonstrated higher levels of protease activity in the disease-associated isolates compared with those from asymptomatic carriers [9] . The N. gonorrhoeae IgA1 protease is capable of digesting human lysosome-associated membrane protein and, thus, could help phagocytosed bacteria escape killing within macrophages [10] . Neisseria is capable of modulating programmed cell death (apoptosis) by blocking the action of TNFα (tumour necrosis factor α). The type II TNF receptor was cleaved specifically after the addition of IgA1 protease, despite the lack of an accepted cleavage site in this protein, implying that the protease recognition site (PP*SP or PP*TP) is not as conserved as originally thought [11] . In addition to blocking cellular responses to cytokines such as TNFα, the N. gonorrhoeae IgA1 protease also has the ability to invoke a potent proinflammatory response in a dose-dependent manner, suggesting that the pathogenic neisseria have the ability to modulate the host response to infection [12] . The release of such cytokines as TNFα and IL-6 (interleukin-6), IL-8 and IL1-β has obvious implications for pathogenesis since these are powerful pro-inflammatory cytokines playing important roles in the pathology of infection [13] .
The enigmatic α-proteins
The H. influenzae IgA1 protease enzymes are approx. 52% identical with their neisserial counterparts. However, the latter possess a distinctive helical domain connecting the protease to β-core. This α-protein domain is made up of a low-complexity sequence, with a high pI value (pI > 10), and is predicted to form coiled-coil interactions. They also contain sequences typical of eukaryotic nuclear localization sequences and differ in length from approx. 180 to 390 amino acids [14] . Previous work suggested that the co-secreted α-protein enters the host cell and translocates to the nucleus [15] . The consequences of this translocation are unknown, but it has been shown that nuclear localization sequences present on the α-protein are indeed capable of nuclear targeting. This ability of the α-protein to enter the host cell nucleus is surely important for the host-pathogen interaction and it is tempting to speculate that it may, in some way, alter host cell gene expression in a way that favours the survival of the bacterium. The helical content of the α-protein prompted Jose et al. [14] to examine the response of human T cells to this bacterial protein. Although some evidence for strain-specific sequence variation within the α-protein coding domains was found, they remained highly conserved. These authors also found short repetitive sequences very similar to T-cell epitopes within the α-proteins. Given that human antibody responses to IgA1 proteases are strong and long lasting, it was inferred that the α-protein might invoke a strong T-helpermediated response to IgA1 protease.
Conclusions
Despite their name, the IgA1 proteases clearly play several roles in the complicated interaction between the bacteria that produce them and their human hosts. The ability to cleave a range of human proteins and to invoke the production of cytokines such as TNFα, IL-1β, IL-2 and IL-6 suggests that this large enzyme plays an important part in the pathology of infection as well as in the maintenance of the carriage state, which is the usual course after exposure to organisms such as N. meningitides and H. influenzae. Further structural studies are needed to unravel the precise mechanisms that cause this large protease domain to cross the bacterial outer membrane. Similarly, the role of the α-protein is yet to be determined fully.
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